Showing results (1211-1220 of 1,334) with videos related to

Sort By:
Pageof 134
Blood|July 2, 2010
High-frequency type I/II mutational shifts between diagnosis and relapse are associated with outcome in pediatric AML: implications for personalized medicineCosta Bachas, Gerrit Jan Schuurhuis, Iris H I M Hollink, et al.
European Journal of Cancer (Oxford, England : 1990)|July 17, 2024
Precision cancer medicine platform trials: Concepts and design of AcSé-ESMARTBirgit Geoerger, Francisco Bautista, Nicolas André, et al.
BMC Pediatrics|May 11, 2017
TropicALL study: Thromboprophylaxis in Children treated for Acute Lymphoblastic Leukemia with Low-molecular-weight heparin: a multicenter randomized controlled trialIrene L M Klaassen, Mandy N Lauw, Marianne D van de Wetering, et al.
Haematologica|July 28, 2022
Analysis of rare driving events in pediatric acute myeloid leukemiaSanne Noort, Jolieke van Oosterwijk, Jing Ma, et al.
Future Oncology (London, England)|March 30, 2018
Accelerating drug development in pediatric cancer: a novel Phase I study design of venetoclax in relapsed/refractory malignanciesAndrew E Place, Kelly Goldsmith, Jean-Pierre Bourquin, et al.
Blood|January 28, 2009
Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemiaIris H I M Hollink, Marry M van den Heuvel-Eibrink, Martin Zimmermann, et al.
Pediatric Blood & Cancer|May 27, 2025
Infectious Morbidity During Pediatric Acute Myeloid Leukemia Chemotherapy in a High-Income Country: A 15-Year Population-Based OverviewEmily R Schwartz, Kim Klein, Birgit I Lissenberg-Witte, et al.
Haematologica|May 19, 2018
Clofarabine, high-dose cytarabine and liposomal daunorubicin in pediatric relapsed/refractory acute myeloid leukemia: a phase IB studyNatasha K A van Eijkelenburg, Mareike Rasche, Essam Ghazaly, et al.
The Lancet. Oncology|July 6, 2017
From class waivers to precision medicine in paediatric oncologyAndrew D J Pearson, Stefan M Pfister, Andre Baruchel, et al.
European Journal of Cancer (Oxford, England : 1990)|May 7, 2023
Hydrocortisone to reduce dexamethasone-induced neurobehavioral side-effects in children with acute lymphoblastic leukaemia-results of a double-blind, randomised controlled trial with cross-over designAnnelienke M van Hulst, Erica L T van den Akker, Emma J Verwaaijen, et al.
Pageof 134